Objective: In response to the well-documented need for evidence-based cancer caregiver support, we examined the feasibility of problem-solving therapy for family caregivers of cancer patients receiving outpatient palliative care and investigated the impact of problem-solving therapy on family caregivers' anxiety, depression, and quality of life.
isolation, and unavailability of necessary information. 3 These stressors can lead to anxiety, depression, fatigue, neglect of self-care, and, for particularly strained caregivers, psychological symptoms that mirror those experienced by trauma survivors. 3, 4 Early studies involving biomarkers have also identified a physiological toll associated with cancer caregiving stress, suggesting that highly stressed FCGs may be at increased risk for morbidity and mortality from certain diseases. 5 The extant literature is clear: Cancer caregiving often takes place in a highly stressful emotional and social context, leaving FCGs vulnerable to significant, potentially long-lasting, adverse effects.
| Family caregiver support in palliative oncology care
Palliative oncology, defined as "the integration into cancer care of therapies to address the multiple issues that cause suffering for patients and their families and impact their quality of life," 6 explicitly espouses a commitment to supporting FCGs. [7] [8] [9] [10] Although commonly misunderstood to be limited to end-of-life care, in the United States palliative oncology is an interdisciplinary service available to patients and families across the full cancer trajectory. Research documenting the multiple benefits of early palliative care 11 has led the American Society of Clinical Oncology (ASCO) to recommend that many patients and families be offered palliative services concurrent with standard oncologic care as early as the time of initial diagnosis, 12 as palliative care can be provided either alongside interventions with a curative intent or as an alternative to disease-directed therapies. Although most palliative oncology in the United States is presently provided on an inpatient basis, it is increasingly being offered in outpatient clinics, 13 creating a potentially ideal opportunity to provide additional support to FCGs in an effort to decrease their distress and improve their quality of life. However, palliative oncology teams wishing to capitalize on this opportunity are limited by the paucity of evidencebased interventions to support FCGs in general 14 and in the outpatient palliative care setting in particular.
| Problem-solving therapy for FCGs
Problem-solving therapy (PST) is a psychosocial intervention that aims to enhance coping effectiveness for individuals facing stressors ranging from daily hassles to major traumatic events. 15 The theoretical framework underpinning PST is the relational/problem-solving model of stress, 16 which conceptualizes psychological distress such as anxiety and depression as the consequence of ineffective coping. The model suggests that, by enhancing problem-solving ability, PST can minimize the negative effects of stressful life events, leading to improved well-being (ie, decreased anxiety and depression and greater quality of life).
While prior studies have identified PST as a promising strategy to reduce distress and improve the quality of life of individuals experiencing stressors associated with cancer caregiving, [17] [18] [19] [20] its feasibility and efficacy as a stand-alone intervention in outpatient palliative oncology settings remains unknown. Thus, in preparation for a large multisite trial, our research team sought to test the feasibility of a PST intervention for FCGs in the ambulatory palliative care setting.
Specifically, we set out to achieve the following aims: (1) 
| Participant recruitment
After securing IRB approval, we recruited study participants from the to allow their participation in a technologically-mediated intervention.
Individuals not receiving formal services from the specialty palliative care clinic were deemed eligible for participation if the patient for whom they provided care was receiving treatment with a palliative intent from the primary oncology team, as understood by the FCG.
Multiple FCGs per patient were allowed to enroll in the study. After the FCG signed the informed consent document, the research nurse opened a numbered sealed envelope, prepared in advance, revealing whether the FCG had been randomly assigned to receive usual care (Group 1) or usual care in addition to PST (Group 2). A CONSORT flow diagram 21 summarizing participant recruitment and randomization is provided in Figure 1 (all participants were analyzed in their randomized groups regardless of their duration in the study). 
| Group 2: usual care plus PST
Family caregivers randomized to Group 2 received usual care in addition to PST. The PST intervention we tested was adapted with permission from Problem-Solving Intervention to Support Caregivers in End-of-Life Settings (or "PISCES") of Demiris et al. 18 Modifications included revised intervention materials that featured cancer-specific examples, referenced palliative care providers, and illustrated the application of problem-solving techniques across the disease and caregiving trajectory.
A trained research nurse delivered the PST intervention to FCGs over three separate sessions, spaced approximately 1 week apart.
Family caregivers were given the option of receiving the intervention by telephone, over web-based videoconferencing, or any combination of the two. All sessions were digitally audio-recorded to permit monitoring of treatment fidelity. The first session focused on topics such as visualizing success, positive self-talk, and using emotions adaptively.
During the second session, FCGs selected a specific caregiving problem and brainstormed possible solutions. In the third and final session, FCGs weighed the pros and cons of various possible solutions to their selected problem, identified a solution (or combination of solutions) they judged to be feasible and likely to result in the most desirable outcome(s), and developed a detailed plan for its implementation.
Through this process, FCGs had the opportunity to learn broadly applicable problem-solving techniques and to apply them to an acute caregiving stressor.
| Study measures

| Feasibility measures
To measure progress toward recruiting and retaining an adequately large study sample, we established monthly recruitment and retention goals (established by a priori power analysis, described in Section 2.4.1) and noted our progress toward achieving them in a shared study database. To measure the degree of fidelity to core intervention components, the study Principal Investigator (PI) or designee reviewed a randomly selected sample of 25% of the audio-recorded intervention sessions and evaluated them using a treatment fidelity assessment form developed specifically for the study. Fidelity scores for each session ranged from 0% to 100%, with a score of 100% reflecting complete fidelity to the intervention protocol.
| Caregiver outcome measures
In addition to reporting basic demographic information, FCGs participating in the study completed standardized instruments measuring their anxiety, depression, and quality of life. The Generalized Anxiety Disorder 7-item scale (GAD-7) 22 measured the frequency with which FCGs experienced symptoms of anxiety such as excessive restlessness, uncontrollable worrying, and irritability. The GAD-7 total scores range from 0 to 21; higher scores reflect greater anxiety.
The GAD-7's internal consistency (Cronbach α = 0.92) and testretest reliability have been supported by prior research. 22 The
Patient Health Questionnaire 9-item scale (PHQ-9) 23 measured the frequency with which respondents experienced symptoms of depression such as anhedonia, sleep disturbance, and impaired concentration. The PHQ-9 total scores range from 0 to 27; higher scores reflect greater depression. The PHQ-9's internal consistency (Cronbach α = 0.89) and test-retest reliability have been supported by prior research. 23 The Caregiver Quality of Life Index-Revised (CQLI-R) 24 measured FCGs' quality of life in four domains: emotional, social, financial, and physical. Total CQLI-R scores range from 0 to 40; higher scores indicate better quality of life. The CQLI-R's FIGURE 1 CONSORT flow diagram internal consistency (Cronbach α = 0.769) and test-retest reliability have been supported by prior research. 24 Family caregivers in both study groups completed the GAD-7, PHQ-9, and CQLI-R according to the same administration schedule, which included the following approximate time points: T 0 (baseline/ study enrollment), T 1 (day 15/intervention midpoint for Group 2), T 2 (day 30/intervention conclusion for Group 2), and T 3 (day 60/study exit). With the exception of baseline measures, which were completed on paper during their enrollment visit, FCGs were given the option of completing the instruments online via Qualtrics (Provo, UT) or by providing their responses verbally by telephone.
| Data analysis 2.4.1 | Statistical power calculation
We based our a priori power calculation on changes in GAD-7 22 total scores, as the instrument measures a key variable of interest (anxiety) and has demonstrated responsiveness to caregiver PST intervention in previous research. 18 Our sample size calculation was based on a one-tailed test of significance and the following assumptions: (1) the difference in GAD-7 total score means between the usual care and intervention groups would be 2 points, the documented clinically significant effect; 22, 25 (2) reflecting an assumption that FCGs would be able to actively participate in research longer than seriously ill patients. Taking these factors into consideration, we concluded that a sample of 41 participants per group (total of 82) would provide 80% power to detect a 2-point difference in GAD-7 total scores.
| Feasibility and outcomes data analysis
We calculated basic descriptive statistics to determine progress toward meeting feasibility goals and conducted ordinary least squares (OLSs) multiple regression 28 to determine the influence of PST on FCGs' anxiety, depression, and quality of life, using the last available measure postbaseline to compare group outcomes. Analyses were performed in R 3.5.0. 29 Beta coefficients and confidence intervals were estimated with a bootstrapping procedure, an analytic approach that has been considered nonparametric, 30 where each estimate was generated based on 1000 resamples. 31 The regressor variable method was used in order to isolate the effect of the intervention 
| RESULTS
Study and intervention feasibility were both supported. We met our recruitment goal 1 month early, enrolling 83 FCGs in 17 months (participant demographic information is summarized in Table 1 ).
Approximately 75% of our sample was retained through 30-day follow-up. Treatment fidelity, which was calculated as the mean percentage of essential intervention elements observed in the sample of audio-recorded sessions, was 97%.
Preliminary analyses indicated that randomization produced equivalent groups in terms of key demographic variables and baseline outcome measures, which were also controlled for in subsequent modeling (see Table 2 ); no statistically significant differences were noted at baseline. Results from OLS modeling, which we conducted to determine if receipt of PST significantly predicted FCGs' anxiety, depression, and quality of life, are summarized in Table 2 . Participants who received the PST intervention reported statistically significantly less anxiety (P = 0.03) than those receiving only usual care. No statistically significant differences were noted for caregiver depression (P = 0.07) or quality of life (P = 0.06).
| DISCUSSION
Data resulting from this feasibility study of a PST intervention for FCGs of patients with cancer receiving outpatient palliative care provide strong support for the feasibility of the intervention. In addition, the study generated preliminary efficacy data highlighting the potential of PST to decrease FCG anxiety, consistent with both pilot work and large-scale testing of PST interventions in different settings and populations. 17, 18, 33, 34 That neither change in quality of life nor depression were shown to differ between participants in the intervention and usual care groups is noteworthy primarily due to these findings' discordance with much of the published literature. 35 As with all outcomes assessed in this feasbility study, the effect of PST on FCGs'
depression and quality of life should be investigated in future studies including a larger sample, particularly because power calculations for the present study were based solely on expected changes in anxiety.
| Study limitations
A number of other study limitations warrant attention. First, with regard to data analysis, the process of resampling via bootstrapping likely resulted in more robust confidence intervals than would otherwise have been generated, especially given the small sample included in this study, 31 underscoring the need for future, large-scale research on the effect of PST for FCGs in outpatient palliative care. Second, the relatively homogenous nature of the study sample must be noted, 
| Clinical implications
Problem-solving therapy is a feasible and promising approach to reducing cancer FCGs' anxiety; however, advocacy aimed at widespread adoption of PST for FCGs in outpatient palliative care would be premature. Additional testing is needed to provide data necessary to ensure responsible use of limited health care resources. In addition,
given the limited number of outpatient specialty palliative care clinics currently in existence, 13 providers may want to carefully consider whether FCG support services such as PST should originate in the palliative care clinic or be provided as a component of standard cancer care. 
